IMMUNEPOTENT CRP plus doxorubicin/cyclophosphamide chemotherapy remodel the tumor microenvironment in an air pouch triple-negative breast cancer murine model
Silvia Elena Santana-Krímskaya(Universidad Autónoma de Nuevo León), Cristina Rodrı́guez-Padilla(Universidad Autónoma de Nuevo León)
Cited by 25
Related Papers
The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth
|Oncology Letters|2017|26
β-D-Glucose-Reduced Silver Nanoparticles Remodel the Tumor Microenvironment in a Murine Model of Triple-Negative Breast Cancer
|International Journal of Molecular Sciences|2024|3